Pot Stocks to Watch-THC Therapeutics, Inc. (THCT)
April 26, 2019 -- InvestorsHub NewsWire -- Microcap Speculators -- With cannabis companies continuing to help investors make large gains, we’re focusing on a few today.
One cannabis company, THC Therapeutics, Inc. (USOTC: THCT), Very recently, announced that it has received patent protection for the dHydronator®, which can reduce moisture content of cannabis to 10% in only 10-14 hours (normally it takes up to 14 days). The US patent office accepted ALL 20 claims for The dHydronator®. The dHydronator® also destroys harmful surface contaminants & pathogens. The term of the patent provides 20 years of protection on the scalable intellectual property for the dHydronator®. This is big news from THCT.
Today we are highlighting: THC Therapeutics, Inc. (USOTC: THCT), MJardin Group, Inc. (MJARF), Village Farms International, Inc. (NASDAQ: VFF), Cresco Labs Inc. (USOTC: CRLBF), and Origin House (USOTC: ORHOF).
THC Therapeutics, Inc. (USOTC: THCT) (Market Cap: $180.987M; Share Price: $13.55) has developed a sanitizing herb dryer, The dHydronator®. Their laboratory-proven product is specifically designed for drying and sanitizing freshly harvested cannabis and herbs. THCT’s product has been tested by two independent laboratories. The testing covered over 6 strains and 9 independent tests to confirm the findings. Over the 9 tests and 6 strains, there was a 4% average increase of THC-A*.
The US patent office has accepted ALL 20 claims for The dHydronator®. The company has received full patent protection for the dHydronator®. Start your research today on THCT.
MJardin Group, Inc. (MJARF) (Market Cap: $142.127M; Share Price: $1.83), a leader in cannabis production, announced the completion of an Agreement (the “Agreement”), whereby the Nova Scotia Mi’kmaq First Nations (“Mi’kmaq”) will own a 51% stake in AtlantiCann Medical Inc. (“AMI”). As a result of the Agreement, MJardin and the Halef Group will own 39% and 10% of AMI, respectively. In connection with the partnership formed under the Agreement, MJardin, the Mi’kmaq and the Halef Group are contemplating expansion of their relationship, including retail.
MJardin is a global cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is based in Denver, Colorado and Toronto, Canada.
Village Farms International, Inc. (NASDAQ: VFF) (Market Cap: $568.341M; Share Price: $11.62) announced recently that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has exercised its option on the existing 1.1 million square foot Delta 2 greenhouse facility currently owned by Village Farms in Delta, British Columbia. The Delta 2 facility is a newer, nearly identical "sister" facility immediately adjacent to the 1.1 million square foot Delta 3 greenhouse facility, which is already one of the largest cannabis production operations in the world. The addition of the Delta 2 greenhouse operation doubles Pure Sunfarms' total production area to 2.2 million square feet and, with conservatively targeted annual production of approximately 75,000 kilograms of dried cannabis, doubles its annual cannabis production potential to approximately 150,000 kilograms.
Village Farms is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Together with its subsidiaries, it produces, markets, and distributes greenhouse-grown tomatoes, bell peppers, and cucumbers in North America. The company operates in two segments, Produce Business and Energy Business. It also owns and operates a 7.0-megawatt power plant that generates and sells electricity to British Columbia Hydro and Power Authority.
Cresco Labs Inc. (USOTC: CRLBF) (Market Cap: $467.439M; Share Price: $12.94) and CannaRoyalty Corp. d/b/a Origin House (USOTC: ORHOF) (Market Cap: $608.258M; Share Price: $9.10) announced a major deal in April that they have entered into a definitive agreement (the "Agreement") pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Origin House (the "Origin House Shares") (the "Transaction"). Under the terms of the Agreement, holders of common shares of Origin House will receive 0.8428 subordinate voting shares of Cresco Labs (the "Cresco Labs Shares") for each Origin House Share (the "Exchange Ratio"). The transaction represents a total consideration of approximately C$1.1 billion on a fully-diluted basis. The transaction represents the largest public company acquisition in the history of the U.S. cannabis industry. The combined entity will be: one of the largest vertically-integrated multi-state cannabis operators in the United States, a leading North American cannabis company by footprint, and one of the largest cannabis brand distributors. According to their press release “the combination of Cresco Labs and Origin House will result in the premier distribution company serving California, the largest cannabis market in the world.”
Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis operating across the United States, the company focuses on entering highly regulated markets with outsized demand potential and strong regulatory structures.
Origin House is a growing cannabis brands and distribution company operating across key markets in the U.S. and Canada, with a strategic focus on becoming a preeminent global house of cannabis brands. Origin House’s foundation is in California, the world’s largest regulated cannabis market, where it delivers over 130 branded cannabis products from 50+ brands to many licensed dispensaries.
Priyanka Goel, CFA
This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a three-month term consulting agreement with THCT dated 2/14/18. The agreement calls for 50,000 restricted shares of THCT per month. This agreement has been amended to $20,000 per month, and 55,000 shares per month and extended for twelve months ending 3/18/2020. All payments were made directly by THC Therapeutics, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. THCT was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.
http://www.regalconsultingllc.com/disclaimer/ legal disclaimer/
Full Legal Disclaimer Click Here.
Company Name: ACR Communication LLC.
Contact Person: Media Manager
Country: United States
SOURCE: Microcap Speculators